Reports

Global Cardiac Troponin Size, Share, Trends, Forecast: By Type: Troponin T, Troponin I; By Site of Testing: Laboratory Testing, Point-of-care Testing; By Application: Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others; By End-Use; By Distribution Channel; Regional Analysis; Competitive Landscape; 2024-2032

Global Cardiac Troponin Market Outlook

The global cardiac troponin market is expected to grow at a CAGR of about 8.00% in the forecast period of 2024-2032, driven by the rising cases of heart failure.

cardiac troponin market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to be a Significant Regional Market for Cardiac Troponin

North America is anticipated to dominate the global cardiac troponin industry in the forecast period. Heart failure is a critical healthcare issue in the United States. It is highly prevalent and has high mortality and morbidity rate. The cost of care for heart diseases is high in the United States. The prevalence of heart failure in the country is expected to increase with an increasingly ageing population, driving the market growth in the region.

The market is also growing due to high expenditure on research and development, major players and their product availability, and the well-established healthcare infrastructure in the region. The increase aids the demand for cardiac biomarkers for cardiovascular disease diagnosis, a rise in the incidence of the acute coronary syndrome (ACS), advancements in the treatment, and growth in demand for point-of-care cardiac testing kits. The key market players' high specificity and sensitivity of these markers to detect cardiac disorders also contribute to the market growth.

Market Segmentations

cardiac troponin market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Troponin, a key regulatory protein of striated muscle's thin filament (actin), comprises three subunits: C, T, and I. Cardiovascular troponins are biomarkers or diagnostic markers used to detect myocardial infarction. Cardiac troponin is found in both skeletal and cardiac muscles, and a rise in cardiac troponin levels in the blood indicates the onset of myocardial infarction.

By type, the market includes:

Troponin T
Troponin I

Based on the site of testing, the market is divided into:

Laboratory Testing
Point-of-care Testing

The major applications of the market are:

Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others

The end-uses of the market include:

Hospitals
Diagnostic Centres
Homecare Settings
Others

The several distribution channels of the market are:

Manufacturer/ Distributor/ Service Provider
Aftermarket

cardiac troponin market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The regional markets for the cardiac troponin industry can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.

Rising Demand for Cardiac Biomarkers to Diagnose Cardiovascular Diseases Augmenting the Market Growth

The global cardiac troponin industry is driven by the rising demand for cardiac biomarkers to diagnose cardiovascular diseases, the increasing prevalence of acute coronary syndrome, and the reduction in the burden of healthcare costs due to faster and acute diagnosis. Patients suffering from acute critical heart conditions require immediate results and quick diagnosis to avoid any causalities. Hence, physicians and doctors demand advanced use of cardiac troponins, pushing researchers and major companies to make investments. Major companies are focusing on the research and development of cardiac troponin tests and are aiming for the approval of new products to retain and enhance market competitiveness. For instance, in June 2018, Beckman Coulter Diagnostics received Health Canada clearance for its new high sensitivity troponin (hsTnI) assay, Access hsTnI, that aids in diagnosing myocardial infarction for patients presenting with chest pain or other ischemic symptoms.

Besides this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. An increase in the geriatric population and a rise in the number of patients suffering from heart attacks and chest pain due to lifestyle changes are expected to drive the market in the coming years.

Key Players in the Global Cardiac Troponin Market

The report gives a detailed analysis of the following key players in the global cardiac troponin industry, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Siemens Healthcare GmbH
Eurolyser Diagnostica GmbH
Beckman Coulter, Inc.
Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report

REPORT FEATURES	DETAILS
Base Year	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Scope of the Report	Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment: Type Site of Testing Application End-Use Distribution Channel Region
Breakup by Type	Troponin T Troponin I
Breakup by Site of Testing	Laboratory Testing Point-of-care Testing
Breakup by Application	Acute Coronary Syndrome Myocardial Infarction Congestive Heart Failure Others
Breakup by End-Use	Hospitals Diagnostic Centres Homecare Settings Others
Breakup by Distribution Channel	Manufacturer/ Distributor/ Service Provider Aftermarket
Breakup by Region	North America United States of America Canada Europe United Kingdom Germany France Italy Others Asia Pacific China Japan India ASEAN Australia Others Latin America Brazil Argentina Mexico Others Middle East and Africa Saudi Arabia United Arab Emirates Nigeria South Africa Others
Market Dynamics	SWOT Porter's Five Forces Key Indicators for Demand Key Indicators for Price
Competitive Landscape	Market Structure Company Profiles Company Overview Product Portfolio Demographic Reach and Achievements Certifications
Companies Covered	Abbott Laboratories F. Hoffmann-La Roche Ltd Siemens Healthcare GmbH Eurolyser Diagnostica GmbH Beckman Coulter, Inc. Others
Report Price and Purchase Option	Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format	Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1   Preface
2   Report Coverage – Key Segmentation and Scope
3   Report Description
   3.1   Market Definition and Outlook
   3.2   Properties and Applications
   3.3   Market Analysis
   3.4   Key Players
4   Key Assumptions
5   Executive Summary
   5.1   Overview
   5.2   Key Drivers
   5.3   Key Developments
   5.4   Competitive Structure
   5.5   Key Industrial Trends
6   Market Snapshot
   6.1   Global
   6.2   Region
7   Opportunities and Challenges in the Market
8   Global Cardiac Troponin Market Analysis
   8.1   Key Industry Highlights
   8.2   Global Cardiac Troponin Historical Market (2018-2023)
   8.3   Global Cardiac Troponin Market Forecast (2024-2032)
   8.4   Global Cardiac Troponin Market by Type
       8.4.1   Troponin T
8.4.1.1 Historical Trend (2018-2023)
           8.4.1.2 Forecast Trend (2024-2032)
       8.4.2   Troponin I
8.4.2.1 Historical Trend (2018-2023)
           8.4.2.2 Forecast Trend (2024-2032)
   8.5   Global Cardiac Troponin Market by Site of Testing
       8.5.1   Laboratory Testing
8.5.1.1 Historical Trend (2018-2023)
           8.5.1.2 Forecast Trend (2024-2032)
       8.5.2   Point-of-care Testing
8.5.2.1 Historical Trend (2018-2023)
           8.5.2.2 Forecast Trend (2024-2032)
   8.6   Global Cardiac Troponin Market by Application
       8.6.1   Acute Coronary Syndrome
8.6.1.1 Historical Trend (2018-2023)
           8.6.1.2 Forecast Trend (2024-2032)
       8.6.2   Myocardial Infarction
8.6.2.1 Historical Trend (2018-2023)
           8.6.2.2 Forecast Trend (2024-2032)
       8.6.3   Congestive Heart Failure
8.6.3.1 Historical Trend (2018-2023)
           8.6.3.2 Forecast Trend (2024-2032)
       8.6.4   Others
   8.7   Global Cardiac Troponin Market by End-Use
       8.7.1   Hospitals
8.7.1.1 Historical Trend (2018-2023)
           8.7.1.2 Forecast Trend (2024-2032)
       8.7.2   Diagnostic Centres
8.7.2.1 Historical Trend (2018-2023)
           8.7.2.2 Forecast Trend (2024-2032)
       8.7.3   Homecare Settings
8.7.3.1 Historical Trend (2018-2023)
           8.7.3.2 Forecast Trend (2024-2032)
       8.7.4   Others
   8.8   Global Cardiac Troponin Market by Distribution Channel
       8.8.1   Manufacturer/ Distributor/ Service Provider
8.8.1.1 Historical Trend (2018-2023)
           8.8.1.2 Forecast Trend (2024-2032)
       8.8.2   Aftermarket
8.8.2.1 Historical Trend (2018-2023)
           8.8.2.2 Forecast Trend (2024-2032)
   8.9 Global Cardiac Troponin Market by Region
       8.9.1    North America
           8.9.1.1    Historical Trend (2018-2023)
           8.9.1.2    Forecast Trend (2024-2032)
       8.9.2    Europe
           8.9.2.1    Historical Trend (2018-2023)
           8.9.2.2    Forecast Trend (2024-2032)
       8.9.3    Asia Pacific
           8.9.3.1    Historical Trend (2018-2023)
           8.9.3.2    Forecast Trend (2024-2032)
       8.9.4    Latin America
             8.9.4.1    Historical Trend (2018-2023)
             8.9.4.2    Forecast Trend (2024-2032)
       8.9.5    Middle East and Africa
           8.9.5.1    Historical Trend (2018-2023)
           8.9.5.2    Forecast Trend (2024-2032)
9    North America Cardiac Troponin Market Analysis
   9.1    United States of America
       9.1.1    Historical Trend (2018-2023)
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023)
        9.2.2    Forecast Trend (2024-2032)
10    Europe Cardiac Troponin Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023)
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023)
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023)
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023)
        10.4.2    Forecast Trend (2024-2032)
    10.5   Others
11    Asia Pacific Cardiac Troponin Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023)
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023)
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023)
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023)
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023)
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Cardiac Troponin Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023)
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023)
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023)
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Cardiac Troponin Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023)
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023)
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023)
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023)
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Abbott Laboratories
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    F. Hoffmann-La Roche Ltd
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Siemens Healthcare GmbH
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Eurolyser Diagnostica GmbH
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Beckman Coulter, Inc.
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Others
16    Key Trends and Developments in the Market

List of Key Figures and Tables

1.   Global Cardiac Troponin Market: Key Industry Highlights, 2018 and 2032
2.   Global Cardiac Troponin Historical Market: Breakup by Type (USD Million), 2018-2023
3.   Global Cardiac Troponin Market Forecast: Breakup by Type (USD Million), 2024-2032
4.   Global Cardiac Troponin Historical Market: Breakup by Site of Testing (USD Million), 2018-2023
5.   Global Cardiac Troponin Market Forecast: Breakup by Site of Testing (USD Million), 2024-2032
6.   Global Cardiac Troponin Historical Market: Breakup by Application (USD Million), 2018-2023
7.   Global Cardiac Troponin Market Forecast: Breakup by Application (USD Million), 2024-2032
8.   Global Cardiac Troponin Historical Market: Breakup by End-Use (USD Million), 2018-2023
9.   Global Cardiac Troponin Market Forecast: Breakup by End-Use (USD Million), 2024-2032
10.   Global Cardiac Troponin Historical Market: Breakup by Distribution Channel (USD Million), 2018-2023
11.   Global Cardiac Troponin Market Forecast: Breakup by Distribution Channel (USD Million), 2024-2032
12.   Global Cardiac Troponin Historical Market: Breakup by Region (USD Million), 2018-2023
13.   Global Cardiac Troponin Market Forecast: Breakup by Region (USD Million), 2024-2032
14.   North America Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2018-2023
15.   North America Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2024-2032
16.   Europe Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2018-2023
17.   Europe Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2024-2032
18.   Asia Pacific Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2018-2023
19.   Asia Pacific Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2024-2032
20.   Latin America Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2018-2023
21.   Latin America Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2024-2032
22.   Middle East and Africa Cardiac Troponin Historical Market: Breakup by Country (USD Million), 2018-2023
23.   Middle East and Africa Cardiac Troponin Market Forecast: Breakup by Country (USD Million), 2024-2032
24.   Global Cardiac Troponin Market Structure.

Key Questions Answered in the Report

What is the growth rate of the global cardiac troponin market?

The global cardiac troponin market will grow at a CAGR of 8.00% between 2024 and 2032.

What are the major industry drivers?

The major drivers of the market include the reduction in the burden of healthcare costs, increasing investments, growing research and development activities, approval of new products, rising awareness among patients and healthcare providers, increase in the geriatric population, rise in the number of patients suffering from heart attacks and chest pain, and changes in lifestyles.

What are the key industry trends in the global cardiac troponin market?

The rising demand for cardiac biomarkers to diagnose cardiovascular diseases and the increasing prevalence of acute coronary syndrome are the key industry trends propelling the market's growth.

What are the major regional markets of the cardiac troponin, according to the EMR report?

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

What are the different types of cardiac troponin in the market?

Troponin T and troponin I are the different types of cardiac troponins in the market.

What are the segments based on the site of testing in the market?

Based on the testing site, the market is divided into laboratory testing and point-of-care testing.

What are the major applications of the market?

The major applications of the market are acute coronary syndrome, myocardial infarction, and congestive heart failure, among others.

What is the end-use of the market?

The end-uses of the market include hospitals, diagnostic centres, and homecare settings, among others.

What are the several distribution channels of the market?

The several distribution channels of the market are manufacturer/ distributor/ service provider and aftermarket.

Who are the key industry players, according to the report?

The major players in the industry are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Eurolyser Diagnostica GmbH, and Beckman Coulter, Inc., among others.

Analyst Review

The global cardiac troponin market has been driven by the increasing prevalence of acute coronary syndrome in the historical period. Aided by the increasing investments and rising demand for cardiac biomarkers to diagnose cardiovascular diseases, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 8.00%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Troponin T and troponin I are the different types of cardiac troponins in the market. Based on the testing site, the market is divided into laboratory testing and point-of-care testing. The major applications of the market are acute coronary syndrome, myocardial infarction, and congestive heart failure, among others. The end-uses of the market include hospitals, diagnostic centres, and homecare settings, among others. The several distribution channels of the market are manufacturer/ distributor/ service provider and aftermarket. The major regional markets for cardiac troponin are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The key players in the cardiac troponin market are Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens Healthcare GmbH, Eurolyser Diagnostica GmbH, and Beckman Coulter, Inc., among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Request Sample

Purchase Full Report

Mini Report

$1699

Selected Sections, One User
Printing Not Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Single User License

$2799

All Sections, One User
One Print Allowed
Email Delivery in PDF
~~Free Limited Customisation~~
~~Post Sales Analyst Support~~
~~50% Discount on Next Update~~

Buy Now

Five User License

$3999

All Sections, Five Users
Five Prints Allowed
Email Delivery in PDF
Free Limited Customisation
Post Sales Analyst Support
~~50% Discount on Next Update~~

Buy Now

Corporate License

$4999

All Sections, Unlimited Users
Unlimited Prints Allowed
Email Delivery in PDF + Excel
Free Limited Customisation
Post Sales Analyst Support
50% Discount on Next Update

Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER